Industry News
Pharmaceutical Industry News
Portland’s Struggle to Solve Its Homeless Crisis
Responses to a story about the challenge to Portland’s “progressive identity.” Also: Trump and the soccer team; justices’ books; patients’ drug choices; student-athletes.
FDA Approves First Pill for Postpartum Depression
Because the pill works faster than other antidepressants and is taken for only two weeks, it may encourage more treatment of the debilitating condition.
From Portugal to Portland
Oregon decriminalized all drugs, and overdoses have surged.
For healthy older people, aspirin could cause more bleeding.
A new analysis of older people who have never had a heart attack or stroke suggests limited protective power of daily low-dose aspirin, and worrisome side effects.
Book Review: ‘In the Blood,’ by Charles Barber
“In the Blood” traces how an engineer and a salesman took on military leaders and Big Pharma to get a revolutionary clotting agent to those in dire need.
Tornado at Pfizer Warehouse Likely to Worsen Shortage of Surgical Drugs
A tornado that damaged a Pfizer plant in North Carolina will likely limit supplies of pain relievers used in surgery and other critical-care drugs.
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiations
The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.
How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy
Gilead delayed a new version of a drug, allowing it to extend the patent life of a blockbuster line of medications, internal documents show.
Tornado Rips Through North Carolina Pfizer Site, Damaging Drug Supplies
Extensive damage occurred at the company’s property in Rocky Mount, and many products used by hospitals appeared to have been affected. This could further exacerbate shortages.
Patients Are Being Crushed by Health Care Bureaucracy
A quarter of insured adults report delayed or missed medical care because of administrative tasks.
How the Birth Control Pill Got Over the Counter
The availability of the pill without a prescription could significantly expand access to contraception.
Over-the-Counter Birth Control Pills Are Coming. What’s Next?
One brand of oral contraceptive will soon be available on pharmacy shelves. What else could follow?
RSV Shot Is Approved for Infants
The respiratory virus is a global killer of babies and young children.
New Study Finds Alzheimer’s Drug Donanemab Can Modestly Slow Memory Decline
A trial of donanemab, an experimental drug, found it modestly slowed the worsening of memory and thinking and worked better in patients at earlier stages and those under 75.
Ozempic y su efecto en ‘ruido de la comida’
En redes sociales, algunas personas que toman estos fármacos dicen que uno de los efectos que experimentan es dejar de pensar constantemente en lo que van a comer.
How Women Feel About an Over-the-Counter Birth Control Pill
Most potential consumers were excited by the prospect, though sticker price and safety were lingering concerns.
F.D.A. Approves First U.S. Over-the-Counter Birth Control Pill
The move could significantly expand access to contraception. The pill is expected to be available in early 2024.
Schumer Asks Judicial Policymakers to End Single-Judge Divisions in Texas
The letter is the latest push by Democratic lawmakers to amend a system in which all cases filed in a particular geographic region are assigned to only one judge.
Substance Abuse Is Climbing Among Seniors
Many aging baby boomers have long histories with drugs, cannabis and alcohol. “The field wasn’t ready for that,” said one expert.
Leqembi: lo que hay que saber sobre el fármaco contra el alzhéimer
Medicare cubrirá gran parte del costo para los pacientes en las primeras fases de la enfermedad, pero esta medicina tiene algunos riesgos y solo ralentiza modestamente el deterioro cognitivo.